Annual CFF
$1.45 M
-$129.73 M-98.90%
31 December 2023
Summary:
RAPT Therapeutics annual cash flow from financing activities is currently $1.45 million, with the most recent change of -$129.73 million (-98.90%) on 31 December 2023. During the last 3 years, it has fallen by -$74.01 million (-98.08%). RAPT annual CFF is now -98.98% below its all-time high of $141.48 million, reached on 31 December 2021.RAPT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
-$701.00 K-100.00%
30 September 2024
Summary:
RAPT Therapeutics quarterly cash flow from financing activities is currently $0.00, with the most recent change of -$701.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$106.00 thousand (-100.00%). RAPT quarterly CFF is now -100.00% below its all-time high of $139.11 million, reached on 30 June 2021.RAPT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$10.20 M
-$106.00 K-1.03%
30 September 2024
Summary:
RAPT Therapeutics TTM cash flow from financing activities is currently $10.20 million, with the most recent change of -$106.00 thousand (-1.03%) on 30 September 2024. Over the past year, it has dropped by -$66.15 million (-86.65%). RAPT TTM CFF is now -92.99% below its all-time high of $145.44 million, reached on 30 September 2021.RAPT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.9% | -100.0% | -86.7% |
| 3 y3 years | -98.1% | -100.0% | -93.0% |
| 5 y5 years | -97.3% | -100.0% | -73.0% |
RAPT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.0% | at low | -100.0% | -93.0% | +604.6% | |
| 5 y | 5 years | -99.0% | at low | -100.0% | -93.0% | +604.6% | |
| alltime | all time | -99.0% | at low | -100.0% | -93.0% | >+9999.0% |
RAPT Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $10.20 M(-1.0%) |
| June 2024 | - | $701.00 K(-92.2%) | $10.30 M(-0.6%) |
| Mar 2024 | - | $9.04 M(+1872.9%) | $10.37 M(+616.4%) |
| Dec 2023 | $1.45 M(-98.9%) | $458.00 K(+332.1%) | $1.45 M(-98.1%) |
| Sept 2023 | - | $106.00 K(-86.2%) | $76.35 M(-6.3%) |
| June 2023 | - | $767.00 K(+561.2%) | $81.49 M(-37.9%) |
| Mar 2023 | - | $116.00 K(-99.8%) | $131.16 M(-0.0%) |
| Dec 2022 | $131.18 M(-7.3%) | $75.36 M(+1335.1%) | $131.18 M(+132.5%) |
| Sept 2022 | - | $5.25 M(-89.6%) | $56.42 M(+9.3%) |
| June 2022 | - | $50.44 M(>+9900.0%) | $51.64 M(-63.2%) |
| Mar 2022 | - | $132.00 K(-78.0%) | $140.31 M(-0.8%) |
| Dec 2021 | $141.48 M | $601.00 K(+27.3%) | $141.48 M(-2.7%) |
| Sept 2021 | - | $472.00 K(-99.7%) | $145.44 M(+0.2%) |
| June 2021 | - | $139.11 M(>+9900.0%) | $145.13 M(+2006.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $1.30 M(-71.5%) | $6.89 M(-90.9%) |
| Dec 2020 | $75.46 M(+51.2%) | $4.56 M(+2663.6%) | $75.46 M(-28.6%) |
| Sept 2020 | - | $165.00 K(-80.9%) | $105.64 M(-0.5%) |
| June 2020 | - | $864.00 K(-98.8%) | $106.14 M(-5.9%) |
| Mar 2020 | - | $69.87 M(+101.1%) | $112.76 M(+126.0%) |
| Dec 2019 | $49.90 M(-5.4%) | $34.74 M(+5140.0%) | $49.90 M(+32.1%) |
| Sept 2019 | - | $663.00 K(-91.1%) | $37.78 M(+1.6%) |
| June 2019 | - | $7.49 M(+6.7%) | $37.18 M(-37.7%) |
| Mar 2019 | - | $7.01 M(-69.0%) | $59.66 M(+13.1%) |
| Dec 2018 | $52.73 M(+75.2%) | $22.62 M(>+9900.0%) | $52.73 M(+75.1%) |
| Sept 2018 | - | $62.00 K(-99.8%) | $30.11 M(+0.2%) |
| June 2018 | - | $29.96 M(>+9900.0%) | $30.05 M(>+9900.0%) |
| Mar 2018 | - | $87.00 K | $87.00 K |
| Dec 2017 | $30.10 M | - | - |
FAQ
- What is RAPT Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for RAPT Therapeutics?
- What is RAPT Therapeutics annual CFF year-on-year change?
- What is RAPT Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly CFF year-on-year change?
- What is RAPT Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for RAPT Therapeutics?
- What is RAPT Therapeutics TTM CFF year-on-year change?
What is RAPT Therapeutics annual cash flow from financing activities?
The current annual CFF of RAPT is $1.45 M
What is the all time high annual CFF for RAPT Therapeutics?
RAPT Therapeutics all-time high annual cash flow from financing activities is $141.48 M
What is RAPT Therapeutics annual CFF year-on-year change?
Over the past year, RAPT annual cash flow from financing activities has changed by -$129.73 M (-98.90%)
What is RAPT Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of RAPT is $0.00
What is the all time high quarterly CFF for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly cash flow from financing activities is $139.11 M
What is RAPT Therapeutics quarterly CFF year-on-year change?
Over the past year, RAPT quarterly cash flow from financing activities has changed by -$106.00 K (-100.00%)
What is RAPT Therapeutics TTM cash flow from financing activities?
The current TTM CFF of RAPT is $10.20 M
What is the all time high TTM CFF for RAPT Therapeutics?
RAPT Therapeutics all-time high TTM cash flow from financing activities is $145.44 M
What is RAPT Therapeutics TTM CFF year-on-year change?
Over the past year, RAPT TTM cash flow from financing activities has changed by -$66.15 M (-86.65%)